PSA.

This thoughtful and comprehensive review attempts to untangle the multi-layered and interconnected underpinnings of racial disparities in prostate cancer outcomes, highlighting the data suggesting that racial groups treated in the exact same ways (e.g., on prospective trials) often achieve equally good outcomes, meaning we have work to do in improving access to the latest and greatest therapies. | Nyame, Eur Urol 2022